Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer
Open Access
- 15 September 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (47) , 83063-83074
Abstract
Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancerKeywords
This publication has 25 references indexed in Scilit:
- BRCA1epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancerEpigenetics, 2012
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian CancerNew England Journal of Medicine, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumorsGenes, Chromosomes and Cancer, 2010
- Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomasMolecular Cancer, 2009
- High-resolution methylation analysis of the BRCA1 promoter in ovarian tumorsCancer Genetics and Cytogenetics, 2005
- Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarkerDrug Resistance Updates, 2004
- EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian CancerCell, 2003
- The Hallmarks of CancerCell, 2000
- Distinct transcription start sites generate two forms of BRCA1 mRNAHuman Molecular Genetics, 1995